TNON — Tenon Medical Income Statement
0.000.00%
Last trade - 00:00
- $2.27m
- -$2.11m
- $2.93m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.054 | 0.044 | 0.16 | 0.691 | 2.93 |
Cost of Revenue | |||||
Gross Profit | 0.035 | 0.026 | 0.105 | -0.641 | 1.24 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 0.587 | 0.58 | 6.62 | 19.4 | 18.7 |
Operating Profit | -0.533 | -0.536 | -6.46 | -18.7 | -15.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.586 | -0.705 | -7.08 | -18.9 | -15.6 |
Net Income After Taxes | -0.586 | -0.705 | -7.08 | -18.9 | -15.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.51 | -0.585 | -7.05 | -18.9 | -15.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.51 | -0.585 | -7.05 | -18.9 | -15.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.453 | -0.521 | -6.27 | -23.6 | -8.59 |
Dividends per Share |